Your browser doesn't support javascript.
The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
Kloc, Malgorzata; Ghobrial, Rafik M.
  • Kloc M; The Houston Methodist Research Institute, Houston, TX 77030, USA; The Houston Methodist Hospital, Department of Surgery, Houston, TX, USA; The University of Texas, M.D. Anderson Cancer Center, Department of Genetics, Houston TX, USA. Electronic address: mkloc@houstonmethodist.org.
  • Ghobrial RM; The Houston Methodist Research Institute, Houston, TX 77030, USA; The Houston Methodist Hospital, Department of Surgery, Houston, TX, USA.
Mult Scler Relat Disord ; 45: 102437, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-688895

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / RhoA GTP-Binding Protein / Enzyme Inhibitors Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Respiratory Distress Syndrome / Coronavirus Infections / RhoA GTP-Binding Protein / Enzyme Inhibitors Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article